Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhizi + chuanxiong is a traditional Chinese medicine (TCM) herbal combination consisting of Zhizi (Fructus Gardeniae) and Chuanxiong (Ligusticum chuanxiong). This herb pair is used primarily for cardiovascular protection, especially in the context of atherosclerosis. Mechanistically, studies indicate that the combination exerts anti-atherosclerotic effects by suppressing inflammatory pathways—specifically inhibiting the TNF/NF-κB axis and reducing M1 macrophage polarization. Experimental data show that it can decrease intima-media thickness, plaque area, serum lipid levels, and markers of inflammation such as TNF-α and IL-1β in animal models. In TCM theory, Zhizi clears heat and dampness while Chuanxiong promotes blood circulation and relieves blood stasis; together they are believed to synergize for enhanced efficacy against vascular inflammation[1][3][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zhizi + chuanxiong.